XPO Other Income (Expense) increased by 50.0% to $3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 200.0%, from $1.00M to $3.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows a downward trend with a -41.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.00M | $19.00M | $15.00M | $14.00M | $13.00M | $15.00M | $13.00M | $5.00M | $3.00M | $4.00M | $3.00M | $10.00M | $6.00M | $15.00M | $6.00M | $1.00M | $2.00M | $2.00M | $2.00M | $3.00M |
| QoQ Change | — | +90.0% | -21.1% | -6.7% | -7.1% | +15.4% | -13.3% | -61.5% | -40.0% | +33.3% | -25.0% | +233.3% | -40.0% | +150.0% | -60.0% | -83.3% | +100.0% | +0.0% | +0.0% | +50.0% |
| YoY Change | — | — | — | — | +30.0% | -21.1% | -13.3% | -64.3% | -76.9% | -73.3% | -76.9% | +100.0% | +100.0% | +275.0% | +100.0% | -90.0% | -66.7% | -86.7% | -66.7% | +200.0% |